Cervical cancer is often missed in the early stages because cervical cancer symptoms can be subtle and easily mistaken for ...
In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...
Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...
Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...
The outcomes of this trial help confirm that cisplatin chemotherapy given adjuvantly with radiotherapy is not a superior alternative ,” said Sang Young Ryu, MD.
Genmab has announced that the European Commission (EC) has approved Tivdak (tisotumab vedotin) to treat recurrent or ...
The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...